Literature DB >> 6491945

Methods for in vitro percutaneous absorption studies III: hydrophobic compounds.

R L Bronaugh, R F Stewart.   

Abstract

The absorption of two hydrophobic compounds through rat skin was measured by in vivo and in vitro techniques. The permeation of the fragrance ingredients 3-phenyl-2-propenyl 2-aminobenzoate (I) and 1-(3-ethyl-5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)+ ethanone (II) was measured from a petrolatum and an acetone vehicle. Increases in permeation of 8-fold (I) and 95-fold (II) were observed when the compounds were tested in vivo under conditions similar to in vitro procedures. The apparent inability of the compounds to freely enter the diffusion cell receptor fluid was partially reversed by replacing normal saline with other fluids: rabbit serum, 3% bovine serum albumin, organic solvents, and dilutions of four nonionic surfactants. The effect of the receptor fluids on the integrity of the skin barrier was assessed by measuring the permeability of control compounds (cortisone, urea, and water). A 6% solution of polyethylene glycol 20 oleyl ether was the receptor fluid of choice. Without apparent damage to the skin, 61% (petrolatum vehicle) or 73% (acetone vehicle) of the in vivo absorption of I was obtained. With II, only 32% of the in vivo absorption was achieved (petrolatum vehicle). Even when the surfactant solution is used, significant differences may still remain between in vivo and in vitro results.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6491945     DOI: 10.1002/jps.2600730916

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  16 in total

Review 1.  Bioequivalence for topical products--an update.

Authors:  Yogeeta Narkar
Journal:  Pharm Res       Date:  2010-09-22       Impact factor: 4.200

2.  In vivo percutaneous absorption: a key role for stratum corneum/vehicle partitioning.

Authors:  A Rougier; M Rallis; P Krien; C Lotte
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

3.  Predicting skin permeability from complex chemical mixtures: dependency of quantitative structure permeation relationships on biology of skin model used.

Authors:  Jim E Riviere; James D Brooks
Journal:  Toxicol Sci       Date:  2010-10-14       Impact factor: 4.849

4.  Mechanistic Evaluation of Hydration Effects on the Human Epidermal Permeation of Salicylate Esters.

Authors:  Shereen Yousef; Yousuf Mohammed; Sarika Namjoshi; Jeffrey Grice; Wedad Sakran; Michael Roberts
Journal:  AAPS J       Date:  2016-09-15       Impact factor: 4.009

5.  Use of excised human skin to assess the bioequivalence of topical products.

Authors:  T J Franz; P A Lehman; S G Raney
Journal:  Skin Pharmacol Physiol       Date:  2009-08-26       Impact factor: 3.479

6.  Evaluation of the membrane permeability (PAMPA and skin) of benzimidazoles with potential cannabinoid activity and their relation with the Biopharmaceutics Classification System (BCS).

Authors:  M Javiera Alvarez-Figueroa; C David Pessoa-Mahana; M Elisa Palavecino-González; Jaime Mella-Raipán; Cristián Espinosa-Bustos; Manuel E Lagos-Muñoz
Journal:  AAPS PharmSciTech       Date:  2011-05-04       Impact factor: 3.246

7.  Development and evaluation of curcumin-loaded elastic vesicles as an effective topical anti-inflammatory formulation.

Authors:  Rumjhum Agrawal; Simarjot Kaur Sandhu; Ikksheta Sharma; Indu Pal Kaur
Journal:  AAPS PharmSciTech       Date:  2014-10-16       Impact factor: 3.246

8.  In vitro and in vivo percutaneous absorption of benzo[a]pyrene from petroleum crude-fortified soil in the rat.

Authors:  J J Yang; T A Roy; A J Krueger; W Neil; C R Mackerer
Journal:  Bull Environ Contam Toxicol       Date:  1989-08       Impact factor: 2.151

9.  In vitro absorption of some chlorinated paraffins through human skin.

Authors:  R C Scott
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

10.  Transdermal delivery of levonorgestrel. V. Preparation of devices and evaluation in vitro.

Authors:  D R Friend; P Catz; J Heller; M Okagaki
Journal:  Pharm Res       Date:  1989-11       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.